Multi-omics and machine learning for the prevention and management of female reproductive health

Abstract

Females typically carry most of the burden of reproduction in mammals. In humans, this burden is exacerbated further, as the evolutionary advantage of a large and complex human brain came at a great cost of women’s reproductive health. Pregnancy thus became a highly demanding phase in a woman’s life cycle both physically and emotionally and therefore needs monitoring to assure an optimal outcome. Moreover, an increasing societal trend towards reproductive complications partly due to the increasing maternal age and global obesity pandemic demands closer monitoring of female reproductive health. This review first provides an overview of female reproductive biology and further explores utilization of large-scale data analysis and -omics techniques (genomics, transcriptomics, proteomics, and metabolomics) towards diagnosis, prognosis, and management of female reproductive disorders. In addition, we explore machine learning approaches for predictive models towards prevention and management. Furthermore, mobile apps and wearable devices provide a promise of continuous monitoring of health. These complementary technologies can be combined towards monitoring female (fertility-related) health and detection of any early complications to provide intervention solutions. In summary, technological advances (e.g., omics and wearables) have shown a promise towards diagnosis, prognosis, and management of female reproductive disorders. Systematic integration of these technologies is needed urgently in female reproductive healthcare to be further implemented in the national healthcare systems for societal benefit.

Insights into Sex and Gender Differences in Brain and Psychopathologies Using Big Data

“…Importantly, the cohorts must target recruitment at specified age ranges, including peri- and post-menopausal women, age-matched men, and underrepresented communities. The continuous improvement in diagnosis, prognosis, and therapy of diseases is accelerated as a result of technology advancements (such as omics and wearables) [ 129 ]. For the benefit of society, there is an urgent need for the systematic integration of these technologies into healthcare and national healthcare systems.…”

Clinical Theragnostic Signature of Extracellular Vesicles in Traumatic Brain Injury (TBI)

“…By identifying patterns and associations between different variables, machine learning algorithms can provide personalized recommendations for treatment based on individual patient characteristics. 116,117 The current research suggests mild TBIs may increase the risk of neurodegenerative diseases later in life if not given sufficient time to recover. 118 These repetitive injuries are common in athletes and military personnel and remain underreported.…”

“… , The next level of complexity lies in exosome toxicity. Exosome toxicity needs more clear scientific investigation for affordable and efficient exosome-based therapeutic approach development for TBI. ,− Therefore, it is important to develop standardized methods for EVs isolation, purification, and analysis to ensure the reproducibility and comparability of results across different studies …”

“…These models can integrate multiple types of omics data, such as transcriptomics, proteomics, and metabolomics, to comprehensively understand disease and treatment response. By identifying patterns and associations between different variables, machine learning algorithms can provide personalized recommendations for treatment based on individual patient characteristics. , …”